Literature DB >> 7512614

Natural killer cell responses in renal transplant patients with cytomegalovirus infection.

H Venema1, A P van den Berg, C van Zanten, W J van Son, M van der Giessen, T H The.   

Abstract

Natural killer (NK) cell function in relation to immunophenotypical signs of NK activation was studied prospectively in 15 renal transplant patients with cytomegalovirus (CMV) infection. NK activity (expressed as the percentage of K562 lysis) before onset of CMV infection reached a median of 6% (range 2-18%), comparable to values observed in noninfected controls [7% (range 7-21%), P < .1]. During CMV infection, NK activity rose to a maximum of 25% (6-60%) (P < .001 vs. controls). Maximal values exceeded the upper level of controls in nine of 15 patients. NK activity was correlated to the number of CD56+HLADR+ cells in the peripheral blood (r = .57, P < .001). These data suggest that NK cells play a role in the recovery from CMV infection in a substantial number of patients and that immunophenotypical analysis of NK activation provides a surrogate marker of NK cell function.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7512614     DOI: 10.1002/jmv.1890420216

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  11 in total

1.  NK cell and Th17 responses are differentially induced in murine cytomegalovirus infected renal allografts and vary according to recipient virus dose and strain.

Authors:  Mao Li; Srinivasa Rao Boddeda; Bo Chen; Qiang Zeng; Trenton R Schoeb; Victoria M Velazquez; Masako Shimamura
Journal:  Am J Transplant       Date:  2018-05-07       Impact factor: 8.086

2.  Determination of natural killer cell function by flow cytometry.

Authors:  K L Kane; F A Ashton; J L Schmitz; J D Folds
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

3.  Cytomegalovirus in hematopoietic stem cell transplant recipients.

Authors:  Per Ljungman; Morgan Hakki; Michael Boeckh
Journal:  Hematol Oncol Clin North Am       Date:  2011-02       Impact factor: 3.722

4.  Ganciclovir prophylaxis improves late murine cytomegalovirus-induced renal allograft damage.

Authors:  Masako Shimamura; Maria C Seleme; Lingling Guo; Ute Saunders; Trenton R Schoeb; James F George; William J Britt
Journal:  Transplantation       Date:  2013-01-15       Impact factor: 4.939

Review 5.  Immunobiology of human cytomegalovirus: from bench to bedside.

Authors:  Tania Crough; Rajiv Khanna
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

6.  Human cytomegalovirus-induced NKG2C(hi) CD57(hi) natural killer cells are effectors dependent on humoral antiviral immunity.

Authors:  Zeguang Wu; Christian Sinzger; Giada Frascaroli; Johanna Reichel; Carina Bayer; Li Wang; Reinhold Schirmbeck; Thomas Mertens
Journal:  J Virol       Date:  2013-05-01       Impact factor: 5.103

7.  Human Cytomegalovirus Infection Increases Both Antibody- and Non-Antibody-Dependent Cellular Reactivity by Natural Killer Cells.

Authors:  Clive M Michelo; Bram van Cranenbroek; Peran Touw; Frans H J Claas; Arnold van der Meer; Irma Joosten
Journal:  Transplant Direct       Date:  2017-11-20

8.  Impact of Desensitization on Antiviral Immunity in HLA-Sensitized Kidney Transplant Recipients.

Authors:  Mieko Toyoda; Bong-Ha Shin; Shili Ge; James Mirocha; David Thomas; Maggie Chu; Edgar Rodriguez; Christine Chao; Anna Petrosyan; Odette A Galera; Ashley Vo; Jua Choi; Alice Peng; Joseph Kahwaji; Stanley C Jordan
Journal:  J Immunol Res       Date:  2017-02-06       Impact factor: 4.818

9.  Killer Immunoglobulin-Like Receptor 2DS2 (KIR2DS2), KIR2DL2-HLA-C1, and KIR2DL3 as Genetic Markers for Stratifying the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients.

Authors:  Dominika Deborska-Materkowska; Agnieszka Perkowska-Ptasinska; Anna Sadowska-Jakubowicz; Jolanta Gozdowska; Michał Ciszek; Joanna Pazik; Agata Ostaszewska; Maciej Kosieradzki; Jacek Nowak; Magdalena Durlik
Journal:  Int J Mol Sci       Date:  2019-01-28       Impact factor: 5.923

10.  Assessing Anti-HCMV Cell Mediated Immune Responses in Transplant Recipients and Healthy Controls Using a Novel Functional Assay.

Authors:  Charlotte J Houldcroft; Sarah E Jackson; Eleanor Y Lim; George X Sedikides; Emma L Davies; Claire Atkinson; Megan McIntosh; Ester B M Remmerswaal; Georgina Okecha; Frederike J Bemelman; Richard J Stanton; Matthew Reeves; Mark R Wills
Journal:  Front Cell Infect Microbiol       Date:  2020-06-26       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.